Stay updated on MEDI0382 Efficacy & Safety in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the MEDI0382 Efficacy & Safety in Type 2 Diabetes Clinical Trial page.

Latest updates to the MEDI0382 Efficacy & Safety in Type 2 Diabetes Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe screenshots show only minor layout and styling adjustments to the Study Details page, with no changes to core study content, endpoints, eligibility criteria, or enrollment figures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check42 days agoChange Detected- Added a prominent operating-status notice and a link guidance, and updated the version to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%

- Check49 days agoChange DetectedUpdated version to v3.1.0 and removed several drug-safety topic items (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while retaining an older revision in deletions (v3.0.2).SummaryDifference0.3%

- Check63 days agoChange DetectedVersion bump from v3.0.1 to v3.0.2; no other content changes detected.SummaryDifference0.1%

- Check71 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%

- Check78 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new drug information related to Liraglutide and a comprehensive list of locations in various countries, while also removing outdated location references and some medical terms.SummaryDifference9%

Stay in the know with updates to MEDI0382 Efficacy & Safety in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI0382 Efficacy & Safety in Type 2 Diabetes Clinical Trial page.